About half of all strokes could be caused by a narrowing of the carotid artery – the pipeline that ushers blood flow through the neck and to the brain. The Bay Area’s Silk Road Medical may have found a less-invasive way to increase the blood flow to the brain, using traditional stenting concepts but kicking ‘em up a notch.
To do so, Silk Road has just raised $15 million from four investors as part of a $22.5 million round, according to regulatory filings. This brings total investment in the company, founded in 2007, to more than $50 million. The company has listed Warburg Pincus and The Vertical Group as its main investors, though more are clearly involved.
Help employers find you! Check out all the jobs and post your resume.
